These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34827276)

  • 1. Potential of Nanoparticles Integrated with Antibacterial Properties in Preventing Biofilm and Antibiotic Resistance.
    Thambirajoo M; Maarof M; Lokanathan Y; Katas H; Ghazalli NF; Tabata Y; Fauzi MB
    Antibiotics (Basel); 2021 Nov; 10(11):. PubMed ID: 34827276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhamnolipid-Coated Iron Oxide Nanoparticles as a Novel Multitarget Candidate against Major Foodborne E. coli Serotypes and Methicillin-Resistant S. aureus.
    Sharaf M; Sewid AH; Hamouda HI; Elharrif MG; El-Demerdash AS; Alharthi A; Hashim N; Hamad AA; Selim S; Alkhalifah DHM; Hozzein WN; Abdalla M; Saber T
    Microbiol Spectr; 2022 Aug; 10(4):e0025022. PubMed ID: 35852338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics.
    Mubeen B; Ansar AN; Rasool R; Ullah I; Imam SS; Alshehri S; Ghoneim MM; Alzarea SI; Nadeem MS; Kazmi I
    Antibiotics (Basel); 2021 Nov; 10(12):. PubMed ID: 34943685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies.
    Singh A; Amod A; Pandey P; Bose P; Pingali MS; Shivalkar S; Varadwaj PK; Sahoo AK; Samanta SK
    Biomed Mater; 2022 Feb; 17(2):. PubMed ID: 35105823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing infections through nanotechnology and nanoparticles.
    Taylor E; Webster TJ
    Int J Nanomedicine; 2011; 6():1463-73. PubMed ID: 21796248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of biofilm-forming pathogenic bacteria in the presence of nanoparticles and antibiotic: adaptation phenomena and cross-resistance.
    Mann R; Holmes A; McNeilly O; Cavaliere R; Sotiriou GA; Rice SA; Gunawan C
    J Nanobiotechnology; 2021 Sep; 19(1):291. PubMed ID: 34579731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on Usage of Functional Nanomaterials in Antimicrobial Therapy for Antibiotic-Resistant Bacterial Infections.
    Karnwal A; Kumar G; Pant G; Hossain K; Ahmad A; Alshammari MB
    ACS Omega; 2023 Apr; 8(15):13492-13508. PubMed ID: 37091369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections.
    Elfadil D; Elkhatib WF; El-Sayyad GS
    Microb Pathog; 2022 Sep; 170():105721. PubMed ID: 35970290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance and biofilm tolerance: a combined threat in the treatment of chronic infections.
    Bowler PG
    J Wound Care; 2018 May; 27(5):273-277. PubMed ID: 29738295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic-Loaded MoS
    Zhang X; Zhang W; Liu L; Yang M; Huang L; Chen K; Wang R; Yang B; Zhang D; Wang J
    Nanotechnology; 2017 Apr; ():. PubMed ID: 28398220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in nanoparticles as antibacterial agent.
    Ozdal M; Gurkok S
    ADMET DMPK; 2022; 10(2):115-129. PubMed ID: 35350114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial Biofilms: Applications, Clinical Consequences, and Alternative Therapies.
    Ali A; Zahra A; Kamthan M; Husain FM; Albalawi T; Zubair M; Alatawy R; Abid M; Noorani MS
    Microorganisms; 2023 Jul; 11(8):. PubMed ID: 37630494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofilm formation to inhibition: Role of zinc oxide-based nanoparticles.
    Mahamuni-Badiger PP; Patil PM; Badiger MV; Patel PR; Thorat-Gadgil BS; Pandit A; Bohara RA
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110319. PubMed ID: 31923962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity interactions drive post-implantation drug filling, even in the presence of bacterial biofilm.
    Cyphert EL; Zuckerman ST; Korley JN; von Recum HA
    Acta Biomater; 2017 Jul; 57():95-102. PubMed ID: 28414173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine-loaded gold nanoparticles: antibiofilm and anti-persister activities against pathogenic bacteria.
    Khan F; Park SK; Bamunuarachchi NI; Oh D; Kim YM
    Appl Microbiol Biotechnol; 2021 May; 105(9):3717-3731. PubMed ID: 33900427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic-loaded MoS
    Zhang X; Zhang W; Liu L; Yang M; Huang L; Chen K; Wang R; Yang B; Zhang D; Wang J
    Nanotechnology; 2017 May; 28(22):225101. PubMed ID: 28480869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrasodium EDTA Is Effective at Eradicating Biofilms Formed by Clinically Relevant Microorganisms from Patients' Central Venous Catheters.
    Liu F; Hansra S; Crockford G; Köster W; Allan BJ; Blondeau JM; Lainesse C; White AP
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30487154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.